| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.12.10.1214 |
| P698 | PubMed publication ID | 1390593 |
| P2093 | author name string | A. Rees | |
| G. Utermann | |||
| E. Boerwinkle | |||
| J. D. Kark | |||
| N. Saha | |||
| W. Jaross | |||
| C. Sandholzer | |||
| F. Hoppichler | |||
| H. Dieplinger | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1214-1226 | |
| P577 | publication date | 1992-10-01 | |
| P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
| P1476 | title | Apo(a) isoforms predict risk for coronary heart disease. A study in six populations | |
| P478 | volume | 12 |
| Q36104114 | 5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family |
| Q94445741 | A genome-wide analysis of DNA methylation identifies a novel association signal for Lp(a) concentrations in the LPA promoter |
| Q35750052 | A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians |
| Q53154011 | A unique pattern of apo(a) polymorphism in an isolated east Greenlandic Inuit (Eskimo) population. |
| Q47447928 | Analysis of the apo(a) size polymorphism in Asian Indian populations: association with Lp(a) concentration and coronary heart disease |
| Q47808578 | Apolipoprotein(a) phenotypes as genetic markers of coronary atherosclerosis severity |
| Q47272541 | Apolipoprotein(a) size polymorphism in young adults with ischemic stroke |
| Q44620563 | Apoprotein(a) phenotypes and plasma lipoprotein(a) concentration in patients with diabetes mellitus |
| Q77958706 | Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age |
| Q72717812 | Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes |
| Q50959234 | Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women. |
| Q36449485 | Association study of lipoprotein(a) genetic markers, traditional risk factors, and coronary heart disease in HIV-1-infected patients. |
| Q33601790 | Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux |
| Q73423924 | Atherosclerosis and arteriosclerosis in chronic renal failure |
| Q38152960 | Causes and consequences of lipoprotein(a) abnormalities in kidney disease |
| Q47255451 | Contribution of apolipoprotein(a) size, pentanucleotide TTTTA repeat and C/T(+93) polymorphisms of the apo(a) gene to regulation of lipoprotein(a) plasma levels in a population of young European Caucasians |
| Q54175051 | Coronary risk factors in people from the Indian subcontinent. |
| Q36718608 | Cys4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly |
| Q55427348 | Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries. |
| Q37130840 | Determination of lipoprotein(a) kringle repeat number from genomic DNA: copy number variation genotyping using qPCR. |
| Q72896857 | Effect of race on lipoprotein profile |
| Q72355343 | Elevated Lp(a) levels in patients with end-stage renal disease |
| Q74445989 | Elevated lipoprotein(a) levels and small apo(a) isoforms are compatible with longevity: evidence from a large population of French centenarians |
| Q34786504 | Enigmatic role of lipoprotein(a) in cardiovascular disease |
| Q40802371 | Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein(a) as risk factors for coronary heart disease |
| Q90269588 | Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outcomes: A Mendelian Randomization Analysis |
| Q83299924 | Ethnicity may be a reason for lipid changes and high Lp(a) levels in rheumatoid arthritis |
| Q35643684 | Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus. |
| Q37314809 | Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review |
| Q28079294 | Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases |
| Q38968510 | Hyperlipoproteinaemia(a) - apheresis and emerging therapies |
| Q47987141 | In search of a biological pattern for human longevity: impact of apo A-IV genetic polymorphisms on lipoproteins and the hyper-Lp(a) in centenarians |
| Q73961084 | Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease |
| Q24796609 | Insulin sensitivity and Lp(alpha) concentrations in normoglycemic offspring of type 2 diabetic parents |
| Q48634633 | Interaction of family history of atherosclerosis with atherogenic lipid traits in men with non-coronary atherosclerosis |
| Q40788018 | Is lipoprotein(a)-cholesterol a better predictor of vascular disease events than total lipoprotein(a) mass? A nested case control study from the West of Scotland Coronary Prevention Study |
| Q48407846 | Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study |
| Q72390883 | Lipids and Lp(a) lipoprotein levels and coronary artery disease in subjects with non-insulin-dependent diabetes mellitus |
| Q34015050 | Lipoprotein (a) and stroke |
| Q30242031 | Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology |
| Q33784377 | Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohorts |
| Q43729975 | Lipoprotein (a) level in the population in Taiwan: relationship to sociodemographic and atherosclerotic risk factors |
| Q50949167 | Lipoprotein (a) serum levels in patients with hepatocarcinoma. |
| Q40964818 | Lipoprotein (a). |
| Q36515765 | Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease |
| Q61560715 | Lipoprotein lipase activity in patients with combined hyperlipidaemia |
| Q51531090 | Lipoprotein(a) and the risk of thromboembolism in Thai children |
| Q77896432 | Lipoprotein(a) as a risk factor for coronary artery disease |
| Q21284797 | Lipoprotein(a) in cardiovascular diseases |
| Q40937490 | Lipoprotein(a) in renal disease |
| Q78004696 | Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up |
| Q90172288 | Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus |
| Q88827413 | Lipoprotein(a) – es wird Zeit, das Dornröschen wach zu küssen |
| Q44434972 | Lipoprotein(a), apolipoprotein(a) polymorphism and restenosis after intracoronary stent placement in Type 2 diabetic patients |
| Q36881908 | Lipoprotein(a), homocysteine, and retinal arteriosclerosis. |
| Q91684402 | Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction |
| Q35746190 | Lipoprotein(a): an elusive cardiovascular risk factor |
| Q34658104 | Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events |
| Q73712815 | Lp(a) and lipids in adult Turner's syndrome: impact of treatment with 17beta-estradiol and norethisterone |
| Q40521691 | Malignant coronary artery disease in young Asian Indians: thoughts on pathogenesis, prevention, and therapy. Coronary Artery Disease in Asian Indians (CADI) Study |
| Q33843614 | Management of selected lipid abnormalities. Hypertriglyceridemia, low HDL cholesterol, lipoprotein(a), in thyroid and renal diseases, and post-transplantation |
| Q35585949 | Management of selected lipid abnormalities: hypertriglyceridemia, isolated low HDL-cholesterol, lipoprotein(a), and lipid abnormalities in renal diseases and following solid organ transplantation |
| Q77482247 | Mortality differences by APOE genotype estimated from demographic synthesis |
| Q42845610 | Oxidation of apolipoprotein(a) inhibits kringle-associated lysine binding: the loss of intrinsic protein fluorescence suggests a role for tryptophan residues in the lysine binding site |
| Q41564035 | Pathophysiological implication of the structural domains of lipoprotein(a). |
| Q39071274 | Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels |
| Q35559549 | Plasma lipoprotein concentrations in ethnic populations |
| Q77714696 | Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention |
| Q31879006 | Prospective association of lipoprotein(a) concentrations and apo(a) size with coronary heart disease among men in the Multiple Risk Factor Intervention Trial |
| Q51588246 | Recombinant human insulin‐like growth factor‐I decreases serum lipoprotein(a) concentrations in normal adult men |
| Q28344927 | Relation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic population |
| Q24792333 | Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects |
| Q37434626 | Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study |
| Q78617653 | Restenosis after intracoronary stent placement: can apolipoprotein(a) polymorphism play a role? |
| Q71606947 | Risk of primary and recurrent acute myocardial infarction from lipoprotein(a) in men and women |
| Q38298100 | Sequence polymorphism in kringle IV 37 in linkage disequilibrium with the apolipoprotein (a) size polymorphism |
| Q78004675 | Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study |
| Q71482538 | Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients |
| Q38807488 | Structure, function, and genetics of lipoprotein (a). |
| Q37442363 | The apolipoprotein(a) gene: linkage disequilibria at three loci differs in African Americans and Caucasians |
| Q43641238 | The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA)(n) polymorphism with coronary heart disease. |
| Q35087598 | The role of non-LDL:non-HDL particles in atherosclerosis |
| Q58071851 | Urinary apo(a) discriminates coronary artery disease patients from controls |
| Q73714721 | [Phenotypic expression of Lp(a) in Spanish children and adolescents] |
Search more.